Risk of agranulocytosis associated to drugs: An approach to the analysis of risks using spontaneous reporting of agranulocytosis associated to calcium dobesilate treatment;Riesgo de agranulocitosis por fármacos: Una aproximación al análisis de riesgos a partir de notificaciones espontáneas de casos de agranulocitosis en pacientes tratados con dobesilato de calcio

Anales de Medicina Interna

Volumn 19, Issue 6, 2002, Pages 275-282

  Zapater Hernández, Pedro ^a   Horga De La Parte, J F ^a   Garcia A G ^b,c  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Adverse drug reaction reporting systems; Agranulocytosis; Calcium dobesilate; Poisson distribution; Risk assessment

Indexed keywords

DOBESILATE CALCIUM;

ADULT; AGE; AGED; AGRANULOCYTOSIS; ARTICLE; DATA ANALYSIS; DRUG INFORMATION; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POISSON DISTRIBUTION; RISK ASSESSMENT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; AGRANULOCYTOSIS; ALGORITHMS; CALCIUM DOBESILATE; CASE-CONTROL STUDIES; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISRAEL; MALE; MIDDLE AGED; MULTICENTER STUDIES; POISSON DISTRIBUTION; PROSPECTIVE STUDIES; RISK ASSESSMENT; SPAIN;

EID: 0036298207     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Incidence of adverse drug reactions in hospitalized patients
2. Hospital admissions caused by iatrogenic disease
3. The importance of adverse reactions in drug regulation
4. Fatal reactions due to drugs. A study of 10 years material from the Swedish Adverse Drug Reaction Committee
5. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study
6. Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia Study
7. Recurrent agranulocytosis after taking calcium dobesilate
8. Agranulocytosis induced by calcium dobesilate
9. Agranulocitosis inducida por dobesilato cálcico: A propósito de un nuevo caso
10. Calcium dobesilate-induced agranulocytosis
11. False-positives in spontaneous reporting: Should we worry about them?
12. Idiosyncratic drug-induced haematological abnormalities
13. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding